Laboratory and hematology diagnostics
HORIBA Yumizen D20
Digital cell morphology system that uses robotics and AI to digitize blood and urine samples and support remote review of pre-classified reports.
Last updated: June 14, 2026
Back to directoryMindray MC-80 medical AI product profile
Automated digital morphology analyzer that captures blood smear images and pre-classifies cells so trained laboratory staff can review morphology more consistently.
Laboratory and hematology diagnostics
Best fit
Labs that need higher-throughput peripheral blood smear review, digital cell images, pre-classification support, and remote expert review while keeping professionals responsible for final interpretation.
- Primary use case
- Automated digital blood cell morphology analysis with advanced algorithms for cell pre-classification, platelet-clump review, remote consultation, and high-throughput smear workflows
- Audience
- Hematology laboratories, laboratory directors, medical technologists, hematopathologists, and health systems standardizing peripheral blood smear review
- Risk level
- High
- Pricing signal
- Analyzer, slide preparation, service, distributor, software, and integration pricing is not public; verify current regional availability and support terms.
- Official sources
- 4 official sources
Compare within workflow: Laboratory and hematology diagnostics · comparison shortlist · source index
Regulatory snapshot
| Status | Official product materials describe MC-80 as an automated digital cell morphology analyzer; verify current IVD registration, CE/IVDR, FDA, and local authorization before clinical use. |
|---|---|
| Review route | Verify local IVD registration and cleared or registered intended use |
| Intended use | Digital morphology support for blood cell image capture, pre-classification, and professional review in hematology laboratory workflows. |
| Verification note | Confirm the exact model, software version, specimen type, remote-review configuration, analyzer integration, and market authorization before purchase or go-live. |
| Source | www.mindray.com / en / products |
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Mindray MC-80 as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as a high-risk in vitro diagnostic morphology workflow. Verify current local registration, intended use, software version, specimen claims, and whether the deployed workflow is cleared or registered in the target market. |
|---|---|
| Privacy | Review slide image storage, sample identifiers, remote-review configuration, LIS connectivity, service access, user permissions, audit logs, exports, and retention across standalone and networked deployments. |
| Evidence | Validate pre-classification against local manual microscopy and abnormal case mix, including immature cells, platelet clumps, rare findings, smear quality, turnaround time, and correction patterns. |
| Workflow | Best governed as technologist- and hematopathologist-reviewed digital morphology support with documented review rules, exception handling, QC monitoring, LIS reconciliation, downtime procedures, and competency checks. |
Where Mindray MC-80 fits
Mindray describes MC-80 as an automated digital cell morphology analyzer using advanced algorithms for clearer images, cell identification, high throughput, platelet-clump review, and remote review. Peer-reviewed evaluations describe MC-80 as an AI-based blood film or automatic morphology analyzer that pre-classifies blood cells, but laboratories still need trained-user review and local validation before clinical reliance.
Not for: Autonomous diagnosis, unreviewed result release, unsupported specimen types, or use without local validation against manual microscopy and laboratory quality-control rules.
What to verify before using Mindray MC-80
- Current IVD registration, CE/IVDR, FDA, distributor, and market availability for the exact MC-80 model, software version, and geography.
- Which workflows are covered: WBC differential, RBC morphology, platelet estimate, platelet clumps, low-quality smears, abnormal cells, and remote consultation.
- How slide images, sample identifiers, operator corrections, remote review access, LIS links, audit logs, service access, and retention are handled.
- Local validation against manual microscopy for normal and abnormal samples, rare cells, platelet flags, turnaround time, operator review burden, and quality-control acceptance criteria.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.mindray.com / en / products
- www.mindray.com / en / media-center
- pubmed.ncbi.nlm.nih.gov / 37641457
- pmc.ncbi.nlm.nih.gov / articles / PMC12282804
Related medical AI products
Laboratory and hematology diagnostics
Scopio Full-Field Digital Cell Morphology
AI-enabled full-field digital cell morphology platform for hematology labs reviewing blood smears and bone marrow aspirates with professional oversight.
Laboratory and hematology diagnostics
Sysmex DI-60
Automated digital cell morphology system that captures and pre-classifies blood cells so trained laboratory staff can review and verify differentials.
Laboratory and hematology diagnostics
CellaVision DC-1
Digital hematology morphology analyzer for lower-volume labs that captures blood smear images and helps staff review pre-classified cells.